What is BEMER electromagnetic field therapy?

BEMER therapy is a low-intensity pulsed electromagnetic field therapy that improves microcirculation and can modulate cellular processes.

How does BEMER therapy affect cancer cells?

BEMER therapy enhances radiosensitivity in cancer cells by increasing reactive oxygen species (ROS) and DNA double strand breaks, improving the effects of radiotherapy.

Does BEMER therapy enhance chemotherapy or Cetuximab?

Current studies show that BEMER therapy does not increase sensitivity to chemotherapy or Cetuximab, and its effect is specific to radiation-induced damage.

Where can I read the full study?

The full study is available at https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5154536/

cancer_cell_and_T_lymphocytes-5a28416422fa3a0037111149

By Norbert physical vascular therapy Study / Publication

BEMER Electromagnetic Field Therapy Enhances Cancer Cell Radiosensitivity

BEMER Electromagnetic Field Therapy Reduces Cancer Cell Radioresistance by Enhanced ROS Formation and Induced DNA Damage

Abstract

Each year more than 450,000 Germans are diagnosed with cancer and receive standard therapies including surgery, chemotherapy, and radiotherapy. Due to intrinsic and acquired resistance, alternative therapeutic support is considered, including non-invasive complementary approaches.

BEMER therapy, a physical vascular therapy applying low-frequency pulsed EMF, normalizes microcirculation and has been investigated for its impact on cancer cell survival during radiotherapy.

Using three-dimensional cell culture models from lung, head and neck, colorectal, and pancreatic cancer, BEMER treatment enhanced radiosensitization, increased ROS levels, and elevated DNA double strand breaks (DSBs). However, it did not sensitize cells to chemotherapy or Cetuximab.

Study Findings

BEMER therapy decreases radioresistance dependent on signal intensity

BEMER therapy applied at 2.7–35 μT 1 hour after 6-Gy X-ray irradiation increased DNA double strand breaks in A549 and UTSCC15 cells, suggesting a link between signal intensity and radiosensitization.

BEMER therapy increases ROS levels leading to radiosensitization

ROS scavengers (sodium pyruvate, MnTBAP, Carboxy-PTIO) were used to test ROS involvement. MnTBAP and Carboxy-PTIO reduced DSB numbers and abrogated radiosensitization, confirming ROS-mediated effects.